Redpoint Investment Management’s Moderna MRNA Stock Holding History

Redpoint Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$943K	Sell	7,971 -1,485	-16%	-$225K	0.14%	186
2022 Q2	$1.35M	Buy	9,456 +699	+8%	+$99.9K	0.16%	155
2022 Q1	$1.51M	Buy	8,757 +760	+10%	+$128K	0.15%	153
2021 Q4	$2.03M	Sell	7,997 -314	-4%	-$91.8K	0.16%	149
2021 Q3	$3.2M	Sell	8,311 -977	-11%	-$360K	0.27%	91
2021 Q2	$2.18M	Buy	9,288 +2,126	+30%	+$380K	0.18%	139
2021 Q1	$938K	Buy	7,162 +3,281	+85%	+$475K	0.08%	291
2020 Q4	$405K	Buy	+3,881	New	+$393K	0.04%	409

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redpoint Investment Management's MRNA Position: Q3 2022 in Review

Redpoint Investment Management reduced its Moderna (MRNA) stake by 16% in Q3 2022, selling an estimated $225K and leaving 7,971 shares worth $943K. The position accounts for 0.14% of the portfolio, ranked #186.

Redpoint Investment Management first reported a position in MRNA in Q4 2020 and has held it in 8 quarters since. The position peaked at $3.2M in Q3 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

Redpoint Investment Management held 7,971 shares of Moderna worth $943K as of Q3 2022.
Redpoint Investment Management sold 1,485 Moderna shares in Q3 2022, an estimated $225K.
Moderna made up 0.14% of Redpoint Investment Management's portfolio in Q3 2022, its #186 holding.
Redpoint Investment Management first reported a position in Moderna in Q4 2020 and has held it in 8 quarters since.
Redpoint Investment Management's Moderna position peaked at $3.2M in Q3 2021.
915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.